Literature DB >> 8258464

Intracellular processing of hapten-modified protein for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes.

S Martin1, G Niedermann, C Leipner, K Eichmann, H U Weltzien.   

Abstract

Phagocytic or endocytic uptake of pH-sensitive liposomes has been shown to result in the release of entrapped material into the cytosol. This system can therefore be applied to the targeted delivery of protein antigens into the MHC class I presentation pathway of antigen-processing cells. We have used trinitrophenyl (TNP)-modified chicken ovalbumin encapsulated in liposomes to examine the intracellular processing of haptenated proteins and the presentation of TNP-modified peptides to MHC class I-restricted hapten-specific CTL. Here, we demonstrate for the first time that hapten-modified proteins can undergo intracellular processing by macrophages, that similar peptides are produced in the form of unmodified or haptenated derivatives, and that TNP-peptides are transported to the cell surface and presented to class I-restricted CTL via the ER/Golgi pathway. This system can now be used to study T-cell responses to naturally processed hapten-conjugated peptides in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258464     DOI: 10.1016/0165-2478(93)90017-v

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

Review 1.  Recent developments in intracellular protein delivery.

Authors:  Yumiao Zhang; Joachim Justad Røise; Kunwoo Lee; Jie Li; Niren Murthy
Journal:  Curr Opin Biotechnol       Date:  2018-02-24       Impact factor: 9.740

2.  Characterization of the Class I MHC Peptidome Resulting From DNCB Exposure of HaCaT Cells.

Authors:  Alistair Bailey; Ben Nicholas; Rachel Darley; Erika Parkinson; Ying Teo; Maja Aleksic; Gavin Maxwell; Tim Elliott; Michael Ardern-Jones; Paul Skipp
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

Review 3.  Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.

Authors:  Dan A Erkes; Senthamil R Selvan
Journal:  J Immunol Res       Date:  2014-05-15       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.